{"id":176171,"date":"2023-11-16T17:23:46","date_gmt":"2023-11-16T23:23:46","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/11\/the-worlds-first-gene-therapy-for-sickle-cell-disease-has-been-approved-in-britain"},"modified":"2023-11-16T17:23:46","modified_gmt":"2023-11-16T23:23:46","slug":"the-worlds-first-gene-therapy-for-sickle-cell-disease-has-been-approved-in-britain","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/11\/the-worlds-first-gene-therapy-for-sickle-cell-disease-has-been-approved-in-britain","title":{"rendered":"The world\u2019s first gene therapy for sickle cell disease has been approved in Britain"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/the-worlds-first-gene-therapy-for-sickle-cell-disease-has-been-approved-in-britain.jpg\"><\/a><\/p>\n<p>LONDON (AP) \u2014 Britain\u2019s medicines regulator has authorized the world\u2019s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K. In a statement Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020. The agency approved\u2026<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LONDON (AP) \u2014 Britain\u2019s medicines regulator has authorized the world\u2019s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K. In a statement Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11],"tags":[],"class_list":["post-176171","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/176171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=176171"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/176171\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=176171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=176171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=176171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}